Products

What will AGI do for Alendronic acid or alendronate sodium?

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C4H13NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1J18R4W8P, chemically known as 4-amino-1-hydroxybutylidene-1,1-bis(phosphonic acid) but generally known as alendronate, which bears US NIH Compound Identifier 2088. Alendronate comes in forms hydrate, sodium, and trihydrate. European Medicines Agency schedules Alendronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05307MIG. The term ALENDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules alendronate in its Anatomical Therapeutic Chemical (ATC) Classification. Alendronic acid or alendronate sodium bears US NLM identifiers UMLS ID C0700482 and NCI Concept Code C973. SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN.

How AGI delivers it

Four ways AGI delivers for Alendronic acid or alendronate sodium

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alendronic acid or alendronate sodium, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alendronic acid or alendronate sodium, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alendronic acid or alendronate sodium connects

measured by

  • Active Ingredient Assaymodel
  • Content Uniformitymodel
  • Dissolution Ratemodel
  • Related Substances Puritymodel
  • Tablet Hardnessmodel